NZ762152A - Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof - Google Patents
Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereofInfo
- Publication number
- NZ762152A NZ762152A NZ762152A NZ76215218A NZ762152A NZ 762152 A NZ762152 A NZ 762152A NZ 762152 A NZ762152 A NZ 762152A NZ 76215218 A NZ76215218 A NZ 76215218A NZ 762152 A NZ762152 A NZ 762152A
- Authority
- NZ
- New Zealand
- Prior art keywords
- sigirr
- nucleic acid
- acid molecules
- disclosure
- receptor related
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554857P | 2017-09-06 | 2017-09-06 | |
| PCT/US2018/049478 WO2019050899A1 (en) | 2017-09-06 | 2018-09-05 | SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 (SIGIRR) RELATED INTERCEPTOR-RELATED VARIANTS AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ762152A true NZ762152A (en) | 2025-11-28 |
Family
ID=63708447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ762152A NZ762152A (en) | 2017-09-06 | 2018-09-05 | Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210071251A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3679158B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7237064B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102752108B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111373053B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018328120B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3074652A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3679158T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3034207T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3679158T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL272940B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020002643A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ762152A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202001754RA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019050899A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5294533A (en) | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| US5135917A (en) | 1990-07-12 | 1992-08-04 | Nova Pharmaceutical Corporation | Interleukin receptor expression inhibiting antisense oligonucleotides |
| US5271941A (en) | 1990-11-02 | 1993-12-21 | Cho Chung Yoon S | Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
| US5786138A (en) | 1993-01-29 | 1998-07-28 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Hyperstabilizing antisense nucleic acid binding agents |
| EP0703979B1 (en) | 1993-06-04 | 2000-09-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method for treating kaposi's sarcoma with antisense oligonucleotides |
| US5578716A (en) | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| US5641754A (en) | 1994-01-10 | 1997-06-24 | The Board Of Regents Of The University Of Nebraska | Antisense oligonucleotide compositions for selectively killing cancer cells |
| WO1996005298A1 (en) | 1994-08-09 | 1996-02-22 | Ciba-Geigy Ag | Antitumor antisense oligonucleotides |
| US5856103A (en) | 1994-10-07 | 1999-01-05 | Board Of Regents The University Of Texas | Method for selectively ranking sequences for antisense targeting |
| US5994320A (en) | 1995-02-06 | 1999-11-30 | Regents Of The University Of Minnesota | Antisense oligonucleotides and methods for treating central nervous system tumors |
| IT1275862B1 (it) | 1995-03-03 | 1997-10-24 | Consiglio Nazionale Ricerche | Trascritto antisenso associato ad alcuni tipi di cellule tumorali ed oligodeossinucleotidi sintetici utili nella diagnosi e nel trattamento |
| US6040296A (en) | 1995-06-07 | 2000-03-21 | East Carolina University | Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation |
| AU7286696A (en) | 1995-10-13 | 1997-05-07 | F. Hoffmann-La Roche Ag | Antisense oligomers |
| KR19990071523A (ko) | 1995-11-21 | 1999-09-27 | 해리 에이. 루스제 | Il－8 및 il－8 수용체에 대한 안티센스올리고누클레오티드에 의한 종양 성장의 억제방법 |
| EP1007655A1 (en) | 1996-02-15 | 2000-06-14 | National Institutes Of Health | Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| US5955590A (en) | 1996-07-15 | 1999-09-21 | Worcester Foundation For Biomedical Research | Conjugates of minor groove DNA binders with antisense oligonucleotides |
| US6046004A (en) | 1997-02-27 | 2000-04-04 | Lorne Park Research, Inc. | Solution hybridization of nucleic acids with antisense probes having modified backbones |
| JPH1142091A (ja) | 1997-07-25 | 1999-02-16 | Toagosei Co Ltd | アンチセンス核酸化合物 |
| US6046319A (en) | 1997-10-22 | 2000-04-04 | University Technologies International, Inc. | Antisense oligodeoxynucleotides regulating expression of TNF-α |
| CA2316034A1 (en) * | 1997-12-23 | 1999-07-01 | Immunex Corporation | Sigirr dna and polypeptides |
| US6007995A (en) | 1998-06-26 | 1999-12-28 | Isis Pharmaceuticals Inc. | Antisense inhibition of TNFR1 expression |
| US6013522A (en) | 1999-02-23 | 2000-01-11 | Isis Pharmaceuticals Inc. | Antisense inhibition of human Smad1 expression |
| US6025198A (en) | 1999-06-25 | 2000-02-15 | Isis Pharmaceuticals Inc. | Antisense modulation of Ship-2 expression |
| US6033910A (en) | 1999-07-19 | 2000-03-07 | Isis Pharmaceuticals Inc. | Antisense inhibition of MAP kinase kinase 6 expression |
| GB2537000C (en) | 2012-05-25 | 2019-10-09 | Univ California | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| CA2891347C (en) | 2012-12-06 | 2018-02-27 | Sigma-Aldrich Co. Llc | Crispr-based genome modification and regulation |
| CN109563516B (zh) | 2016-07-28 | 2023-10-27 | 雷杰纳荣制药公司 | Gpr156变体及其用途 |
-
2018
- 2018-09-05 US US16/644,650 patent/US20210071251A1/en active Pending
- 2018-09-05 AU AU2018328120A patent/AU2018328120B2/en active Active
- 2018-09-05 DK DK18779488.8T patent/DK3679158T3/da active
- 2018-09-05 WO PCT/US2018/049478 patent/WO2019050899A1/en not_active Ceased
- 2018-09-05 ES ES18779488T patent/ES3034207T3/es active Active
- 2018-09-05 JP JP2020513609A patent/JP7237064B2/ja active Active
- 2018-09-05 FI FIEP18779488.8T patent/FI3679158T3/fi active
- 2018-09-05 CN CN201880071851.1A patent/CN111373053B/zh active Active
- 2018-09-05 MX MX2020002643A patent/MX2020002643A/es unknown
- 2018-09-05 NZ NZ762152A patent/NZ762152A/en unknown
- 2018-09-05 IL IL272940A patent/IL272940B2/en unknown
- 2018-09-05 EP EP18779488.8A patent/EP3679158B1/en active Active
- 2018-09-05 KR KR1020207009809A patent/KR102752108B1/ko active Active
- 2018-09-05 CA CA3074652A patent/CA3074652A1/en active Pending
- 2018-09-05 SG SG11202001754RA patent/SG11202001754RA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020002643A (es) | 2020-09-25 |
| KR102752108B1 (ko) | 2025-01-10 |
| EP3679158A1 (en) | 2020-07-15 |
| WO2019050899A1 (en) | 2019-03-14 |
| IL272940B2 (en) | 2024-06-01 |
| IL272940A (en) | 2020-04-30 |
| DK3679158T3 (da) | 2025-06-23 |
| JP2020537495A (ja) | 2020-12-24 |
| FI3679158T3 (fi) | 2025-06-18 |
| US20210071251A1 (en) | 2021-03-11 |
| EP3679158B1 (en) | 2025-04-30 |
| RU2020112474A (ru) | 2021-10-06 |
| IL272940B1 (en) | 2024-02-01 |
| SG11202001754RA (en) | 2020-03-30 |
| JP7237064B2 (ja) | 2023-03-10 |
| CA3074652A1 (en) | 2019-03-14 |
| AU2018328120B2 (en) | 2024-11-14 |
| KR20200058435A (ko) | 2020-05-27 |
| RU2020112474A3 (cg-RX-API-DMAC7.html) | 2021-12-29 |
| CN111373053A (zh) | 2020-07-03 |
| CN111373053B (zh) | 2024-07-30 |
| ES3034207T3 (en) | 2025-08-13 |
| AU2018328120A1 (en) | 2020-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA40882B1 (fr) | Molécules de liaison d'antigène comprenant un trimère de ligand de la famille tnf | |
| CL2017002237A1 (es) | Proteína de unión de il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias. | |
| MX385868B (es) | Proteina de union a interleucina 18 (il-18bp) en enfermedades inflamatorias. | |
| PH12019500596A1 (en) | Recombinant binding proteins and their use | |
| BR112016016411A2 (pt) | VARIANTES DE REGIÕES-"Fc" COM PROPRIEDADES DE LIGAÇÃO DE "FcRn" MODIFICADAS | |
| NZ760289A (en) | Interleukin-2 fusion proteins and uses thereof | |
| CU24058B1 (es) | Antagonistas de pcsk9 | |
| WO2015117088A3 (en) | Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-43 | |
| MX2020000186A (es) | Ensayos para evaluar los niveles de anticuerpos neutralizantes en sujetos tratados con un fármaco biológico y usos de los mismos en medicina personalizada. | |
| WO2009095489A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
| MX2024013403A (es) | Variantes de gpr156 y usos de estas | |
| WO2015198243A3 (en) | Compositions and methods for long acting proteins | |
| MX380889B (es) | Lactoferrina para uso en el diagnóstico o el pronóstico de la enfermedad de alzheimer o en el diagnóstico de la enfermedad de parkinson. | |
| CO2020014681A2 (es) | Proteínas de unión al receptor de cannabinoides tipo 1 (cb1) y usos de las mismas | |
| NZ762152A (en) | Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof | |
| Quan et al. | Kinetics of IL-23 and IL-12 secretion in response to Toxoplasma gondii antigens from THP-1 monocytic cells | |
| Nahm et al. | Proteomic identification of altered cerebral proteins in the complex regional pain syndrome animal model | |
| ZA202101755B (en) | Medicinal composition containing monoclonal antibody or antibody fab fragment thereof, and use thereof | |
| Onishi et al. | New Autoantigens Associated with Lupus Nephritis.: 1610 | |
| Bogdan et al. | The expression of the PIBF protein in mice during pregnancy: P-83 | |
| MX2020002644A (es) | Variantes del miembro 1 de la familia 14 del grupo portador de solutos (slc14a1) y usos de estas. | |
| TH1701000202A (th) | การทำให้เกิดการกลายพันธุ์เฉพาะตำแหน่งของแอนติบอดี trem-1 เพื่อลดความหนืด | |
| Kalokairinou | Ethical and Legal Aspects of Direct-to-consumer Genetic Testing in Europe | |
| Domanova et al. | Autoimmune regulation of pathogenesis of chronic gingivitis and periodontal disease | |
| Vijayalaxmi et al. | Reply from the Authors| Journal of Reproductive Immunology-Volume 69, Issue 1 |